An Homage to the Treg Graft in Allogeneic Transplantation

Less Is More: Low-Dose Direct Oral Anticoagulants for Extended Venous Thromboembolism Prophylaxis in Higher-Risk Patients

GATA Lot to Learn: Decoding the Drivers of Down Syndrome-Associated Acute Leukemias

More Than Medicine: Peer Connection as a Therapeutic Adjunct in Acute Leukemia

Pomalidomide: A Step on the PATH Forward for Treatment of Hereditary Hemorrhagic Telangiectasia

Dual BCR::ABL1 Inhibition Shows Promise in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

When to STOP Treatment for Immune Thrombocytopenia in Patients Experiencing a Complete Response on Thrombopoietin Receptor Agonists

No Scientific Link Found Between Sickle Cell Trait and Sudden Death

Does This Star ‘GLO’? Taking Aim at Second-Line Diffuse Large B-Cell Lymphoma With Glofitamab Plus Gemcitabine and Oxaliplatin

The Rise of the HLA-Mismatched Unrelated Donor Transplant in the U.S.

The End of Transplant for Mantle Cell Lymphoma

DREAMMing of a Better Tomorrow: Belantamab-Based Triplet Therapy for Relapsed/Refractory Multiple Myeloma

Haploidentical Stem Cell Transplantation Is an Acceptable Transformative Therapy for Young Adults With Sickle Cell Disease

Enhancing Risk Stratification for Pediatric B-Cell Acute Lymphoblastic Leukemia: No Longer a ‘PI’ in the Sky Idea?

A Leap of Faith? Elimination of Autologous Stem Cell Transplantation for Patients With Mantle Cell Lymphoma in First Remission

Anticoagulation Stewardship

Blood Global Hematology Editor-in-Chief Shares Vision

One on One With Dr. Fred Appelbaum

Genetic Switch System Suggests Targeting of Mutant JAK2 Reverses Myeloproliferative Neoplasms

Venous Thromboembolism Risk Markers and Discontinuing Combined Hormonal Contraceptives